Is this you?
Request access for Lillestol Research LLC with your @lillestolresearch.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
Lillestol Research LLC
Unclaimed profileIndependent Site · Fargo, North Dakota · ~1 sites
Intera lens
ICP 7Lift (cardio sample) 0.43Recruit soph 0.57
Quality Scorecard (1–100)
Overall68Recruit77Ops77Sponsor54Ther58
Performance (observed)
Historical trials
135
Completed
96
Terminated/Withdrawn
6
Completion rate
94%
Active now
33
Phase 2
42
Phase 3
83
Realized enrollment
511,736
First study year
2000
Years active
26
Match confidence
high
Enrollment velocity (inf)
19,682
Therapeutic
Areas
Type 2 Diabetes, Obesity, Cardiovascular Disease, Diabetic Peripheral Neuropathic Pain, Chronic Pain
Specialties
Diabetes, obesity, cardiovascular, chronic pain, diabetic neuropathy
Breadth (conditions)
94
States
North Dakota
Recruitment (web observed)
Trial Finder
Yes
Patient database
Y (extensive diabetic/metabolic patient base)
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Y - 23 active trials, Veeva listing shows strong presence
Capability notes
High - 23 active trials, large patient database (20k+)
Relationships
Sponsors
Eli Lilly and Company; Pfizer; Novo Nordisk A/S; Amgen; Boehringer Ingelheim; Astellas Pharma Global Development, Inc.
CROs
Premier Research
Owner / parent
Private; founder-led (Dr. Michael & Mary Lillestol founded in 2004)
Expansion
Unknown recent expansion
Recent hiring
Y - Laboratory Coordinator/Phlebotomy positions
Capacity & people
Investigators
—
Coordinators
—
CEO
Michael J. Lillestol, MD, FACP (President)
VP Clinical Ops
Mary L. Lillestol, RN (VP/CFO)
VP Site Ops
Jamie M. Brown, PA-C (Director of Operations)
VP Recruitment
Kimberly Peterson (COO)
Emails
unitedstates@bitrialsupport.com
Tech & DCT
CTMS
Unknown (Veeva listing suggests possible use)
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Single-location site in Fargo, ND, operational since 2004. Strong cardiometabolic focus. ClinicalTrials.gov validation: 6 active recruiting cardiometabolic trials. 20k+ patient database, 23 total active trials, 126 total trials conducted. Founder-led structure with family involvement. Good recruitment signals and patient engagement.
Recommendation features (sample indication)
Ind fit 1.00Liftability 0.43Overall68
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.